Kazuhiro Tabata

1.5k total citations
75 papers, 697 citations indexed

About

Kazuhiro Tabata is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Kazuhiro Tabata has authored 75 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 13 papers in Surgery. Recurrent topics in Kazuhiro Tabata's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Lung Cancer Diagnosis and Treatment (12 papers) and Medical Imaging and Pathology Studies (9 papers). Kazuhiro Tabata is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Lung Cancer Diagnosis and Treatment (12 papers) and Medical Imaging and Pathology Studies (9 papers). Kazuhiro Tabata collaborates with scholars based in Japan, United States and Germany. Kazuhiro Tabata's co-authors include Junya Fukuoka, Suguru Yonezawa, Michiyo Higashi, Seiya Yokoyama, Meera Hameed, Yukako Yagi, Rania G. Aly, Tomayoshi Hayashi, Chihaya Koriyama and Takashi Hori and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Kazuhiro Tabata

70 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuhiro Tabata Japan 14 260 151 151 136 120 75 697
Efrat Ofek Israel 13 302 1.2× 191 1.3× 212 1.4× 81 0.6× 82 0.7× 32 805
I Weng Lao China 15 294 1.1× 123 0.8× 191 1.3× 45 0.3× 49 0.4× 34 597
Mikhail Lisovsky United States 16 211 0.8× 144 1.0× 199 1.3× 107 0.8× 87 0.7× 47 814
Camilla Nero Italy 22 136 0.5× 204 1.4× 289 1.9× 78 0.6× 86 0.7× 89 1.2k
Ruud Clarijs Netherlands 15 234 0.9× 282 1.9× 248 1.6× 79 0.6× 299 2.5× 19 942
Bartłomiej Grala Poland 13 81 0.3× 147 1.0× 145 1.0× 64 0.5× 80 0.7× 31 527
Hyeyoon Chang South Korea 13 134 0.5× 155 1.0× 282 1.9× 83 0.6× 75 0.6× 28 578
Xiaochu Yan China 13 136 0.5× 254 1.7× 289 1.9× 153 1.1× 99 0.8× 33 801
Xiao‐Guang Ni China 9 133 0.5× 142 0.9× 198 1.3× 51 0.4× 47 0.4× 34 535
Rouzan G. Karabakhtsian United States 13 117 0.5× 139 0.9× 180 1.2× 67 0.5× 56 0.5× 34 599

Countries citing papers authored by Kazuhiro Tabata

Since Specialization
Citations

This map shows the geographic impact of Kazuhiro Tabata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiro Tabata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiro Tabata more than expected).

Fields of papers citing papers by Kazuhiro Tabata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhiro Tabata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiro Tabata. The network helps show where Kazuhiro Tabata may publish in the future.

Co-authorship network of co-authors of Kazuhiro Tabata

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiro Tabata. A scholar is included among the top collaborators of Kazuhiro Tabata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiro Tabata. Kazuhiro Tabata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okamoto, Masaki, Toyoshi Yanagihara, Yoshiaki Zaizen, et al.. (2025). Ability of patient-reported outcomes to predict progression-free survival in patients with mild to moderate fibrosing interstitial lung disease. Respiratory Investigation. 63(5). 955–963.
2.
Zaizen, Yoshiaki, Hidenobu Ishii, Shinichi Sumita, et al.. (2025). The Impact of Adverse Events in Transbronchial Lung Cryobiopsy on Histopathological Diagnosis. Journal of Clinical Medicine. 14(3). 731–731. 1 indexed citations
3.
Okamoto, Masaki, Toyoshi Yanagihara, Kiminori Fujimoto, et al.. (2024). Exercise-Induced Oxygen Desaturation and Outcomes After Nintedanib Therapy for Fibrosing Interstitial Lung Disease in Patients Without Dyspnea. Journal of Clinical Medicine. 13(24). 7865–7865. 1 indexed citations
4.
Yonezawa, Hajime, et al.. (2024). Therapeutic effects of an ALK inhibitor, brigatinib, on lung large cell neuroendocrine carcinoma with EML4-ALK fusion. Respiratory Investigation. 62(6). 1157–1160. 2 indexed citations
5.
Okamoto, Masaki, Kiminori Fujimoto, Toyoshi Yanagihara, et al.. (2024). Predictive factors of progression in mild fibrosing interstitial lung disease patients with gender-age-physiology score of 3 or less. Respiratory Investigation. 63(1). 109–117. 1 indexed citations
6.
Umeda, Yukihiro, Ryoko Egashira, Kazuhiro Tabata, et al.. (2023). Human T-cell Lymphotropic Virus Type-1-associated Bronchioloalveolar Disorder with Non-necrotizing Granulomas: A Case Report and Literature Review. Internal Medicine. 63(8). 1149–1155.
7.
Tasaki, Takashi, Eisuke Shiba, Hirotsugu Noguchi, et al.. (2023). Low-grade Fibromyxoid Sarcoma With Massive Degeneration: A Case of Unusual Gross and Histological Features. In Vivo. 37(6). 2863–2868. 1 indexed citations
8.
Zaizen, Yoshiaki, Yasuhiko Yamano, Reoto Takei, et al.. (2022). Sensitivity of transbronchial lung cryobiopsy in the diagnosis of different interstitial lung diseases. Scientific Reports. 12(1). 22037–22037. 3 indexed citations
9.
Takumi, Koji, Hiroaki Nagano, Yoshihiko Fukukura, et al.. (2022). Feasibility of iodine concentration and extracellular volume fraction measurement derived from the equilibrium phase dual-energy CT for differentiating thymic epithelial tumors. Japanese Journal of Radiology. 41(1). 45–53. 8 indexed citations
10.
Higashi, Michiyo, Taiji Hamada, Ken Sasaki, et al.. (2022). Esophageal plexiform fibromyxoma: A case report with molecular analysis for MALAT1-GLI1 fusion. Pathology - Research and Practice. 233. 153878–153878. 10 indexed citations
11.
Kobayashi, Yusuke, Toshiaki Akahane, Tomomi Yamaguchi, et al.. (2021). ATM immunohistochemistry as a potential marker for the differential diagnosis of no specific molecular profile subtype and POLE-mutation subtype endometrioid carcinoma. Pathology - Research and Practice. 230. 153743–153743. 6 indexed citations
12.
Takei, Reoto, Yasuhiko Yamano, Kensuke Kataoka, et al.. (2019). Usefulness of new diagnostic criteria for chronic hypersensitivity pneumonitis established on the basis of a Delphi survey: A Japanese cohort study. Respiratory Investigation. 58(1). 52–58. 12 indexed citations
13.
Yagi, Yukako, Rania G. Aly, Kazuhiro Tabata, et al.. (2018). OA03.07 Three-Dimensional Immunofluorescence Analysis of Dynamic Vessel Co-Option of Spread Through Air Spaces (STAS) in Lung Cancer. Journal of Thoracic Oncology. 13(10). S327–S327. 4 indexed citations
14.
Hashimoto, Shintaro, Naoya Yamasaki, Ryoichiro Doi, et al.. (2017). [Granuloma by Foreign Body Reaction to the Stapler Used for Partial Resection of the Lung].. PubMed. 70(3). 187–190. 2 indexed citations
15.
Isomoto, Hajime, Hiroki Kurumi, Tsutomu Kanda, et al.. (2017). Expression of coproporphyrinogen oxidase is associated with detection of upper gastrointestinal carcinomas by 5-aminolevulinic acid-mediated photodynamic diagnosis. Photodiagnosis and Photodynamic Therapy. 19. 15–21. 7 indexed citations
16.
Nakamura, Sayuri, Kentarō Hayashi, Yuki Imaoka, et al.. (2017). Intratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer. PLoS ONE. 12(10). e0186192–e0186192. 44 indexed citations
17.
Tanaka, Tomonori, Toshiyuki Nakayama, Kyoko Otani, et al.. (2016). Pulmonary alveolar proteinosis-like change: A fairly common reaction associated with the severity of idiopathic pulmonary fibrosis. Respiratory Investigation. 54(4). 272–279. 2 indexed citations
18.
Higashi, Michiyo, Norishige Yamada, Seiya Yokoyama, et al.. (2012). Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type. Pathobiology. 79(2). 101–106. 59 indexed citations
19.
Nagano, Satoshi, Masahiro Yokouchi, Kazuhiro Tabata, et al.. (2011). Bilobular calcifying fibrous pseudotumor in soleus muscle: a case report. Journal of Medical Case Reports. 5(1). 487–487. 5 indexed citations
20.
Nakamura, Yoshihiro, et al.. (2008). A case of paragonimiasis Westermani with pneumothorax at onset. The Journal of the Japanese Association for Chest Surgery. 22(6). 910–913. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026